Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)
1 clinical trials · Condition
◉ Watch Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)
| Record | Firm | Date |
|---|---|---|
| Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) (NCT01634763) | Novartis Pharmaceuticals | 2012-06-01 |
Track Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) automatically
Every clearance here is in the API, with alerts when new ones post.